Seelos Therapeutics SEEL Stock
Seelos Therapeutics Price Chart
Seelos Therapeutics SEEL Financial and Trading Overview
| Seelos Therapeutics stock price | 0.46 USD |
| Previous Close | 1.1 USD |
| Open | 1.12 USD |
| Bid | 0 USD x 4000 |
| Ask | 0 USD x 1200 |
| Day's Range | 1.05 - 1.17 USD |
| 52 Week Range | 0.58 - 1.52 USD |
| Volume | 532.77K USD |
| Avg. Volume | 465.5K USD |
| Market Cap | 127.9M USD |
| Beta (5Y Monthly) | 1.930755 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -7.73 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.25 USD |
SEEL Valuation Measures
| Enterprise Value | 136.71M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.5609756 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 158.29399 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 169.198 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Seelos Therapeutics Stock Price History
| Beta (5Y Monthly) | 1.930755 |
| 52-Week Change | 56.71% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.52 USD |
| 52 Week Low | 0.58 USD |
| 50-Day Moving Average | 0.86 USD |
| 200-Day Moving Average | 0.88 USD |
SEEL Share Statistics
| Avg. Volume (3 month) | 465.5K USD |
| Avg. Daily Volume (10-Days) | 692.67K USD |
| Shares Outstanding | 121.81M |
| Float | 118.38M |
| Short Ratio | 12.65 |
| % Held by Insiders | 2.81% |
| % Held by Institutions | 19.89% |
| Shares Short | 5.48M |
| Short % of Float | 4.62% |
| Short % of Shares Outstanding | 4.50% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -8148.26% |
| Gross Margin | 637.25% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -87.23% |
| Return on Equity (ttm) | -584.20% |
Income Statement
| Revenue (ttm) | 808K USD |
| Revenue Per Share (ttm) | 0.007 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -72964000 USD |
| Diluted EPS (ttm) | -0.68 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 14.06M USD |
| Total Cash Per Share (mrq) | 0.12 USD |
| Total Debt (mrq) | 16.78M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.602 |
| Book Value Per Share (mrq) | -0.17 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -54907000 USD |
| Levered Free Cash Flow (ttm) | -16162500 USD |
Profile of Seelos Therapeutics
| Country | United States |
| State | NY |
| City | New York |
| Address | 300 Park Avenue |
| ZIP | 10022 |
| Phone | 646 293 2100 |
| Website | https://seelostherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 16 |
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, a peptidic inhibitor to treat patients with PD; SLS-008 for the treatment of pediatric indications; SLS-004 for the treatment of PD; SLS-010, an H3 receptor antagonist; and SLS-012. The company was founded in 2016 and is headquartered in New York, New York.
Q&A For Seelos Therapeutics Stock
What is a current SEEL stock price?
Seelos Therapeutics SEEL stock price today per share is 0.46 USD.
How to purchase Seelos Therapeutics stock?
You can buy SEEL shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Seelos Therapeutics?
The stock symbol or ticker of Seelos Therapeutics is SEEL.
Which industry does the Seelos Therapeutics company belong to?
The Seelos Therapeutics industry is Biotechnology.
How many shares does Seelos Therapeutics have in circulation?
The max supply of Seelos Therapeutics shares is 13.68M.
What is Seelos Therapeutics Price to Earnings Ratio (PE Ratio)?
Seelos Therapeutics PE Ratio is now.
What was Seelos Therapeutics earnings per share over the trailing 12 months (TTM)?
Seelos Therapeutics EPS is -7.73 USD over the trailing 12 months.
Which sector does the Seelos Therapeutics company belong to?
The Seelos Therapeutics sector is Healthcare.
Seelos Therapeutics SEEL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}